JY
VIGL

Jeff Yass’s Vigil Neuroscience VIGL Stock Holding History

Jeff Yass’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-212,640
Closed -$378K – 13789
2025
Q1 		$378K Sell
212,640
-24
-0% -$54 ﹤0.01% 9536
2024
Q4 		$362K Buy
+212,664
New +$628K ﹤0.01% 9408
2024
Q3 		– Sell
-48,051
Closed -$192K – 13120
2024
Q2 		$192K Buy
+48,051
New +$164K ﹤0.01% 10415
2023
Q2 		– Sell
-58,718
Closed -$575K – 13215
2023
Q1 		$575K Buy
58,718
+31,343
+114% +$352K ﹤0.01% 8228
2022
Q4 		$342K Buy
+27,375
New +$336K ﹤0.01% 8779

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Jeff Yass's VIGL Position: Q2 2025 in Review

Jeff Yass sold out of Vigil Neuroscience (VIGL) in Q2 2025, closing a stake of 212,640 shares — an estimated $378K sold.

Jeff Yass first reported a position in VIGL in Q4 2022 and held it in 5 quarters. The position peaked at $575K in Q1 2023. 78 funds tracked by Wall St. Rank hold VIGL as of Q2 2025.

  • Jeff Yass reported no remaining Vigil Neuroscience position as of Q2 2025 after selling out during the quarter.
  • Jeff Yass sold 212,640 Vigil Neuroscience shares in Q2 2025, an estimated $378K.
  • Jeff Yass first reported a position in Vigil Neuroscience in Q4 2022 and held it in 5 quarters.
  • Jeff Yass's Vigil Neuroscience position peaked at $575K in Q1 2023.
  • 78 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.